Cloned (Comment) | Organism |
---|---|
gene LARS2, expression analysis, generation of the isolated C-terminal domain of human mt leucyl-tRNA synthetase | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | generation of the isolated C-terminal domain of human mt leucyl-tRNA synthetase, and of DELTACterm mutant | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
mitochondrion | - |
Homo sapiens | 5739 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q15031 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
cybrid cell | transmitochondrial, osteosarcoma-derived (143B.TK-) cybrid cell lines from patients | Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
LARS2 | - |
Homo sapiens |
Leucyl-tRNA synthetase | - |
Homo sapiens |
mt leucyl-tRNA synthetase | - |
Homo sapiens |
mt-LeuRS | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
malfunction | the C-terminal domain of human mt leucyl-tRNA synthetase is both necessary and sufficient to improve the pathologic phenotype associated either with these mild mutations or with the severe m.3243A>G mutation in the mt-tRNALeu(UUR) gene, overview. The small, non-catalytic domain is able to directly and specifically interact in vitro with human mt-tRNALeu(UUR) with high affinity and stability and, with lower affinity, with mt-tRNAIle. The carboxyterminal domain of human mt leucyl-tRNA synthetase can be used to correct mt dysfunctions caused by mt-tRNA mutations. The Cterm domain of human mt-LeuRS directly interacts with mt-tRNALeu(UUR) and mt-tRNAIle in vitro | Homo sapiens |
additional information | three human mitochondrial aminoacyl-tRNA syntethases, namely leucyl-, valyl-, and isoleucyl-tRNA synthetase are able to improve both viability and bioenergetic proficiency of human transmitochondrial cybrid cells carrying pathogenic mutations in the mt-tRNAIle gene | Homo sapiens |